XML 40 R29.htm IDEA: XBRL DOCUMENT v3.21.2
EQUITY AWARDS (Tables)
9 Months Ended
Sep. 30, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of Stock Option Activity

A summary of stock option activity in the Plan during the nine months ended September 30, 2021 and 2020 follows:

 

Nine Months Ended September 30, 2021

 

Number of
Shares

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Life in
Years

 

 

Aggregate
Intrinsic
Value

 

Outstanding at beginning of year

 

 

506,200

 

 

$

26.81

 

 

 

5.82

 

 

$

1,805

 

Effect of 10% stock dividend

 

 

50,770

 

 

 

 

 

 

 

 

 

 

Granted

 

 

45,500

 

 

 

33.49

 

 

 

9.59

 

 

 

107

 

Exercised

 

 

(48,630

)

 

 

22.89

 

 

 

3.82

 

 

 

630

 

Forfeited

 

 

(19,020

)

 

 

26.01

 

 

 

6.84

 

 

 

187

 

Balance, September 30, 2021

 

 

534,820

 

 

$

25.22

 

 

 

5.53

 

 

$

5,684

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable at end of period

 

 

307,786

 

 

$

23.78

 

 

 

4.33

 

 

$

3,715

 

 

 

Nine Months Ended September 30, 2020

 

Number of
Shares

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Life in
Years

 

 

Aggregate
Intrinsic
Value

 

Outstanding at beginning of year

 

 

508,000

 

 

$

26.68

 

 

 

6.24

 

 

$

3,159

 

Granted

 

 

39,000

 

 

 

27.43

 

 

 

9.51

 

 

 

24

 

Exercised

 

 

(3,000

)

 

 

24.00

 

 

 

2.04

 

 

 

3

 

Forfeited

 

 

(37,600

)

 

 

29.68

 

 

 

8.12

 

 

 

24

 

Balance, September 30, 2020

 

 

506,400

 

 

$

26.53

 

 

 

5.62

 

 

$

304

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable at end of period

 

 

302,220

 

 

$

25.55

 

 

 

4.77

 

 

$

244

 

Schedule of Nonvested Stock Option Activity

A summary of nonvested stock option activity in the Plan during the nine months ended September 30, 2021 and 2020 follows:

 

Nine Months Ended September 30, 2021

 

Number of
Shares

 

 

Weighted-Average
Grant
Date Fair Value

 

Outstanding at beginning of year

 

 

214,680

 

 

$

4.46

 

Effect of 10% stock dividend

 

 

23,218

 

 

 

 

Granted

 

 

45,500

 

 

 

5.82

 

Vested

 

 

(47,344

)

 

 

(5.72

)

Forfeited

 

 

(9,020

)

 

 

(8.06

)

Balance, September 30, 2021

 

 

227,034

 

 

$

5.11

 

 

Nine Months Ended September 30, 2020

 

Number of
Shares

 

 

Weighted-Average
Grant
Date Fair Value

 

Outstanding at beginning of year

 

 

251,120

 

 

$

4.97

 

Granted

 

 

39,000

 

 

 

3.86

 

Vested

 

 

(53,340

)

 

 

(6.07

)

Forfeited

 

 

(32,600

)

 

 

(2.20

)

Balance, September 30, 2020

 

 

204,180

 

 

$

5.54

 

Plan Information

Information related to stock options in the Plan is as follows for the nine months ended:

 

 

 

September 30, 2021

 

 

September 30, 2020

 

Intrinsic value of options exercised

 

$

630

 

 

$

3

 

Cash received from options exercised

 

 

1,113

 

 

 

72

 

Weighted average fair value of options granted

 

 

5.82

 

 

 

3.86

 

 

Summary of Restricted Stock Awards and Units Activity

A summary of restricted stock activity in the Plan during the nine months ended September 30, 2021 and 2020 follows:

 

Nine Months Ended September 30, 2021

 

Number of
Shares

 

 

Weighted-Average
 Grant
Date Fair Value

 

Outstanding at beginning of year

 

 

35,300

 

 

$

29.72

 

Effect of 10% stock dividend

 

 

3,530

 

 

 

 

Granted

 

 

3,500

 

 

 

33.09

 

Vested

 

 

(7,850

)

 

 

27.26

 

Forfeited

 

 

 

 

 

 

Balance, September 30, 2021

 

 

34,480

 

 

$

27.41

 

 

Nine Months Ended September 30, 2020

 

Number of
Shares

 

 

Weighted-Average
Grant
 Date Fair Value

 

Outstanding at beginning of year

 

 

31,459

 

 

$

30.29

 

Granted

 

 

 

 

 

 

Vested

 

 

(13,380

)

 

 

30.30

 

Forfeited

 

 

 

 

 

 

Balance, September 30, 2020

 

 

18,079

 

 

$

30.28